Acuitive Technologies is a privately held medical device manufacturer based in Allendale, New Jersey, founded in 2014 by four orthopedic-industry veterans. The company builds implants around its CITREGEN citrate-based bioresorbable biomaterial, licensed from Northwestern University and Penn State research, sold as soft-tissue fixation screws and anchors (CITRELOCK, CITREFIX), a rotator-cuff scaffold (CITREBRIDGE) and a synthetic bone graft substitute (CITREGRAFT) used in sports-medicine and foot-and-ankle procedures. It received its first FDA 510(k) clearance in 2020 and commercializes its products through orthopedic distribution partners.
1
Round
1
Industry
4
Tags
Sep 24, 2026
Latest raise
Funding activity · 1 round
Sep 24, 2026
$1.9M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
